Akèy › Twoub psikotik
Etid klinik pou Twoub psikotik ap rekrite nan Etazini
75 etid pou Twoub psikotik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- San Diego, CA10 etid
- Boston, MA9 etid
- New York City, NY7 etid
- Dallas, TX6 etid
- Cambridge, MA6 etid
- Queens, NY5 etid
- Miami, FL5 etid
- Los Angeles, CA5 etid
- Hartford, CT4 etid
- Pittsburgh, PA4 etid
- Austin, TX4 etid
- Parma, OH4 etid
- Tampa, FL4 etid
- Anaheim, CA4 etid
- Chicago, IL3 etid
- Athens, GA3 etid
- Minneapolis, MN3 etid
- West Palm Beach, FL3 etid
- Orange, CA3 etid
- Naples, FL3 etid
- Bellevue, WA3 etid
- Augusta, GA3 etid
- Orlando, FL3 etid
- Long Beach, CA3 etid
- Baltimore, MD3 etid
- Houston, TX3 etid
- Worcester, MA3 etid
- San Antonio, TX3 etid
- Grand Prairie, TX3 etid
- Cape Coral, FL3 etid
- Atlanta, GA3 etid
- Nashville, TN3 etid
- Chino, CA3 etid
- Cleveland, OH3 etid
- Hialeah, FL3 etid
Pa eta
- Arizona3 etid
- Connecticut5 etid
- Florid8 etid
- Georgia10 etid
- Illinois5 etid
- Kalifòni20 etid
- Maryland5 etid
- Massachusetts13 etid
- Michigan3 etid
- Minnesota4 etid
- New Jersey5 etid
- New York16 etid
- North Carolina4 etid
- Ohio7 etid
- Pennsylvania6 etid
- Tennessee3 etid
- Texas14 etid
- Washington4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
iTBS to Enhance Social Cognition in People With Psychosis
Ap rekrite
Laj 18 a 39 · Tout sèks · Mizajou Oct 1, 2026 · NCT06118268A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT06887192Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Sep 30, 2026 · NCT06835556A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06540833A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT06585787State Representation in Early Psychosis 2
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 15 a 45 · Tout sèks · Mizajou Sep 22, 2026 · NCT07834203A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07105111A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 1, 2026 · NCT07459647Cerebellar Modulation of Cognition in Psychosis
Ap rekrite
Laj 18 a 55 · Tout sèks · Mizajou Aug 20, 2026 · NCT06107764Enhancing Veteran-Clinical Collaboration in VA PRRCs
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT06898879Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
Ap rekrite
Laj 18 a 45 · Tout sèks · Mizajou Aug 17, 2026 · NCT06221852REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)
Ap rekrite
Laj 18 a 50 · Tout sèks · Mizajou Aug 17, 2026 · NCT07006935Changing Lives and Changing Outcomes-9 at Worcester Recovery Center and Hospital
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT07359157Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy
Ap rekriteFaz 2/3
Laj 18 a 90 · Tout sèks · Mizajou Aug 12, 2026 · NCT06529029Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
Ap rekriteFaz 1
Laj 10 a 17 · Tout sèks · Mizajou Aug 11, 2026 · NCT05025605Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
Ap rekrite
Laj 18 a 45 · Tout sèks · Mizajou Aug 4, 2026 · NCT05890183BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis
Ap rekrite
Laj 16 a 30 · Tout sèks · Mizajou Jul 29, 2026 · NCT07417904Determining the Role of Social Reward Learning in Social Anhedonia
Ap rekrite
Laj 18 a 35 · Tout sèks · Mizajou Jul 27, 2026 · NCT05617898Cognitive Strategies in Early Psychosis 2
Ap rekriteFaz 3
Laj 18 a 35 · Tout sèks · Mizajou Jul 23, 2026 · NCT07263022Transition Care for FEP
Ap rekriteEtid obsèvasyon
Laj 18 a 40 · Tout sèks · Mizajou Jul 20, 2026 · NCT07713849Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness
Ap rekriteVolontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Jul 16, 2026 · NCT04940663MicroRNAs as Biomarkers in First Episode Schizophrenia
Ap rekriteVolontè an sante akeyi
Laj 15 a 40 · Tout sèks · Mizajou Jul 14, 2026 · NCT07703670Exercise and Olanzapine-samidorphan
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Jul 13, 2026 · NCT06740890A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT05537376Anticholinergic Deprescription in Schizophrenia
Ap rekriteFaz 4Volontè an sante akeyi
Laj 40 a 70 · Tout sèks · Mizajou Jul 10, 2026 · NCT06562608Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.